Page last updated: 2024-11-05

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Adhesions, Tissue

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Adhesions, Tissue in 1 studies

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strowitzki, MJ1
Ritter, AS1
Radhakrishnan, P1
Harnoss, JM1
Opitz, VM1
Biller, M1
Wehrmann, J1
Keppler, U1
Scheer, J1
Wallwiener, M1
Schmidt, T1
Ulrich, A1
Schneider, M1

Other Studies

1 other study available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Adhesions, Tissue

ArticleYear
Pharmacological HIF-inhibition attenuates postoperative adhesion formation.
    Scientific reports, 2017, 10-13, Volume: 7, Issue:1

    Topics: Animals; Cell Differentiation; Enzyme-Linked Immunosorbent Assay; Epithelial-Mesenchymal Transition;

2017